Patents by Inventor Robert E. Lee

Robert E. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975907
    Abstract: A device, system, and method for maintaining temperature control of a distribution item, or of the contents of a distribution item, as the distribution item moves through the distribution network. A container housing an item can include a cooling unit, a heating unit, or both, and control circuitry including a temperature sensor. The control circuitry activates the cooling unit or heating unit as required to maintain the item at a desired temperature or within a desired temperature range.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: May 7, 2024
    Assignee: United States Postal Service
    Inventors: James Edward Lee, Sr., Ryan M. Luckay, Robert E. Dixon, Jr.
  • Patent number: 11701796
    Abstract: A system includes a mandrel contoured to define a tapering tubular shape of a workpiece cured on the mandrel and a demolding tool. The demolding tool is configured to remove the workpiece from the mandrel after the workpiece is cured on the mandrel and cut longitudinally. The demolding tool is configured to remove the workpiece from the mandrel by deforming a first end of the workpiece to at least partially disengage the first end of the workpiece from a first end of the mandrel, and subsequently, deforming a second end of the workpiece to at least partially disengage the second end of the workpiece from a second end of the mandrel. The first end of the workpiece may have a first cross-sectional area that is smaller than a second cross-sectional area of the second end of the workpiece.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: July 18, 2023
    Assignee: THE BOEING COMPANY
    Inventors: Courtney Michele Fix, Robert Wayne Murray, Paul Diep, Robert E. Lee, Richard A. Skilton, Ronald Leroy McGhee, Zachary Nathaniel Stoddard, Patrick B. Stone, Phillip Andrew Taylor, Nickolas Scott Ellerbeck
  • Patent number: 11627134
    Abstract: Disclosed are various embodiments for facilitating the cancellation or reversion of unauthorized operations. An operation initiated to be executed with respect to a user account is received from a computing device that has been authenticated. A notification of the operation is sent through at least one communication channel in response to receiving the operation. The notification facilitates a reply that causes the operation to be cancelled when the reply is sent within a first time period and causes the operation to be reverted when the reply is sent within a second time period after an expiration of the first time period.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: April 11, 2023
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Robert E. Lee, Harnil C. Rafalia, Bradley Vivian Quadros
  • Patent number: 11475745
    Abstract: A security system is provided. The security system includes a control panel located within a secured space, a plurality of sensors coupled to the control panel that detect security events within the secured space, a user interface within the secured area coupled to the control panel, a camera located in the user interface that collects video images in the secured space surrounding the user interface upon activation of one of the plurality of sensors, a sound transducer located in the user interface, a programmed processor within one of the user interface and the control panel that supports VoIP calls between a called or calling party and the user interface and a control button on the user interface that activates a VoIP connection with a called or calling party through the user interface and control panel.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: October 18, 2022
    Assignee: Ademco Inc.
    Inventors: Kenneth G. Eskildsen, Robert E. Lee
  • Patent number: 11414435
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: August 16, 2022
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Denis Daigle, Bin Liu, Daniel McGarry, Daniel C. Pevear, Robert E. Lee Trout, Randy W. Jackson
  • Publication number: 20220193958
    Abstract: A system includes a mandrel contoured to define a tapering tubular shape of a workpiece cured on the mandrel and a demolding tool. The demolding tool is configured to remove the workpiece from the mandrel after the workpiece is cured on the mandrel and cut longitudinally. The demolding tool is configured to remove the workpiece from the mandrel by deforming a first end of the workpiece to at least partially disengage the first end of the workpiece from a first end of the mandrel, and subsequently, deforming a second end of the workpiece to at least partially disengage the second end of the workpiece from a second end of the mandrel. The first end of the workpiece may have a first cross-sectional area that is smaller than a second cross-sectional area of the second end of the workpiece.
    Type: Application
    Filed: November 15, 2021
    Publication date: June 23, 2022
    Inventors: Courtney Michele Fix, Robert Wayne Murray, Paul Diep, Robert E. Lee, Richard A. Skilton, Ronald Leroy McGhee, Zachary Nathaniel Stoddard, Patrick B. Stone, Phillip Andrew Taylor, Nickolas Scott Ellerbeck
  • Publication number: 20220194964
    Abstract: Disclosed herein are crystalline forms of ((2-Ethylbutanoyl)oxy)methyl (R)-2-hydroxy-3-propionamido-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylate. Also disclosed herein are methods of treating a bacterial with a crystalline form of ((2-Ethylbutanoyl)oxy)methyl (R)-2-hydroxy-3-propionamido-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylate.
    Type: Application
    Filed: April 1, 2020
    Publication date: June 23, 2022
    Inventors: Christopher J. BURNS, Lawrence ROSEN, Stephen M. CONDON, Eugen F. MESAROS, Allison L. ZULLI, Robert E. Lee TROUT, Yijun DENG, Steven A. BOYD, Robert SIMPSON
  • Patent number: 11332485
    Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: May 17, 2022
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Denis Daigle, Guo-Hua Chu, Jodie Hamrick, Matthew Lucas, Steven A. Boyd, Allison L. Zulli, Eugen F. Mesaros, Stephen M. Condon, Robert E. Lee Trout, Cullen L. Myers
  • Publication number: 20220125812
    Abstract: The present invention relates to pharmaceutical compositions containing boron-containing compounds and their use as inhibitors of beta-lactamase enzymes and as antibacterial agents in combination with a beta-lactam antibiotic.
    Type: Application
    Filed: November 22, 2019
    Publication date: April 28, 2022
    Inventors: Christopher J. BURNS, Denis DAIGLE, Jodie HAMRICK, Daniel C. PEVEAR, Robert E. Lee TROUT, Luigi XERRI, Timothy HENKEL, Cullen L. MYERS, Stephen M. CONDON, Anthony DRAGER, Lawrence ROSEN
  • Publication number: 20210198288
    Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Application
    Filed: May 23, 2019
    Publication date: July 1, 2021
    Inventors: Christopher J. BURNS, Denis DAIGLE, Guo-Hua CHU, Jodie HAMRICK, Steven A. BOYD, Allison L. ZULLI, Eugen F. MESAROS, Stephen M. CONDON, Robert E. Lee TROUT, Cullen L. MYERS, Zhenrong XU
  • Patent number: 11008346
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: May 18, 2021
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Denis Daigle, Bin Liu, Randy W. Jackson, Jodie Hamrick, Daniel McGarry, Daniel C. Pevear, Robert E. Lee Trout
  • Patent number: 10933743
    Abstract: A power-take off (PTO) system for a vehicle having a powertrain comprising an engine and a hybrid electric transmission includes a PTO device configured to provide power to an accessory load of the vehicle, a housing for a gear clutch of the transmission, the housing being formed of steel, needle bearings for the gear clutch, and a gear defined by or attached to an outer surface of the housing, wherein at least one electric motor of the transmission is configured to drive the PTO device via the gear clutch and the gear while the engine is disconnected from the transmission or is shut off.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: March 2, 2021
    Assignee: FCA US LLC
    Inventors: Tejinder Singh, James E Adams, Robert E Lee
  • Publication number: 20200361962
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Application
    Filed: February 21, 2020
    Publication date: November 19, 2020
    Inventors: Christopher J. BURNS, Denis DAIGLE, Bin LIU, Randy W. JACKSON, Jodie HAMRICK, Daniel McGARRY, Daniel C. PEVEAR, Robert E. Lee TROUT
  • Publication number: 20200317698
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Application
    Filed: May 1, 2020
    Publication date: October 8, 2020
    Inventors: Christopher J. BURNS, Denis DAIGLE, Bin LIU, Daniel McGARRY, Daniel C. PEVEAR, Robert E. Lee TROUT, Randy W. JACKSON
  • Patent number: 10669290
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: June 2, 2020
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Denis Daigle, Bin Liu, Daniel McGarry, Daniel C. Pevear, Robert E. Lee Trout
  • Publication number: 20200157123
    Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Application
    Filed: May 25, 2018
    Publication date: May 21, 2020
    Inventors: Christopher J. BURNS, Denis DAIGLE, Guo-Hua CHU, Jodie HAMRICK, Matthew LUCAS, Steven A. Boyd, Allison L. ZULLI, Eugen F. MESAROS, Stephen M. CONDON, Robert E. Lee TROUT, Cullen L. MYERS
  • Patent number: 10565360
    Abstract: The disclosed embodiments provide a system that manages access to a computer-based resource. During operation, the system obtains a request for the computer-based resource, wherein the request identifies a user seeking access to the computer-based resource. Next, the system obtains a set of security levels for a set of identity-proofing techniques, wherein the set of security levels is based on a first set of success rates of the identity-proofing techniques in preventing fraudulent access to computer-based resources. The system then calculates an identity assurance level for the user based on the set of security levels and a second set of success rates of the user in completing one or more of the identity-proofing techniques. Upon determining that the identity assurance level of the user meets a minimum identity assurance level for accessing the computer-based resource, the system enables access to the computer-based resource in a response to the request.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 18, 2020
    Assignee: INTUIT INC.
    Inventors: Robert E. Lee, Thomas M. Pigoski, II, Douglas L. Foiles
  • Patent number: 10464952
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: November 5, 2019
    Assignee: VENATORX PHARMACEUTICALS, INC.
    Inventors: Christopher J. Burns, Daniel C. Pevear, Robert E. Lee Trout, Randy W. Jackson, Jodie Hamrick, Allison L. Zulli, Eugen F. Mesaros, Steven A. Boyd
  • Publication number: 20190225628
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Application
    Filed: January 2, 2019
    Publication date: July 25, 2019
    Inventors: Christopher J. BURNS, Denis DAIGLE, Bin LIU, Daniel McGARRY, Daniel C. PEVEAR, Robert E. Lee TROUT
  • Patent number: 10294248
    Abstract: Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: May 21, 2019
    Assignee: VenatoRx Pharmaceuticals, Inc.
    Inventors: Christopher J. Burns, Denis Daigle, Bin Liu, Daniel McGarry, Daniel C. Pevear, Robert E. Lee Trout